124 related articles for article (PubMed ID: 17972805)
1. [The impairments of natural killer cell activity and interferon response in advanced malignant disease].
Draca S
Srp Arh Celok Lek; 1994; 122(1-2):48-50. PubMed ID: 17972805
[TBL] [Abstract][Full Text] [Related]
2. The participation of natural cytotoxicity in the control of malignant disease.
Draca SR
Panminerva Med; 1993 Sep; 35(3):123-6. PubMed ID: 8090524
[TBL] [Abstract][Full Text] [Related]
3. Defects in natural killer cell activity and interferon response in human lung carcinoma and malignant melanoma.
Sibbitt WL; Bankhurst AD; Jumonville AJ; Saiki JH; Saiers JH; Doberneck RC
Cancer Res; 1984 Feb; 44(2):852-6. PubMed ID: 6198076
[TBL] [Abstract][Full Text] [Related]
4. [The effect of sera of breast cancer patients on NK cell activity].
Konjević G; Spuzić I
Srp Arh Celok Lek; 1995; 123(9-10):227-31. PubMed ID: 17974436
[TBL] [Abstract][Full Text] [Related]
5. Dysfunction of natural killer cells in multiple sclerosis: a possible pathogenetic factor.
Benczur M; Petrányl GG; Pálffy G; Varga M; Tálas M; Kotsy B; Földes I; Hollán SR
Clin Exp Immunol; 1980 Mar; 39(3):657-62. PubMed ID: 6155232
[TBL] [Abstract][Full Text] [Related]
6. Basic and interferon-augmented natural killer (NK) cell activity in psoriasis.
Jansén CT; Viander M
Acta Derm Venereol; 1983; 63(5):384-7. PubMed ID: 6197835
[TBL] [Abstract][Full Text] [Related]
7. Natural killer cell activity of prostatic cancer patients.
Choe BK; Frost P; Morrison MK; Rose NR
Cancer Invest; 1987; 5(4):285-91. PubMed ID: 2444316
[TBL] [Abstract][Full Text] [Related]
8. Direct and natural killer cell-mediated antitumor effects of low-dose bortezomib in hepatocellular carcinoma.
Armeanu S; Krusch M; Baltz KM; Weiss TS; Smirnow I; Steinle A; Lauer UM; Bitzer M; Salih HR
Clin Cancer Res; 2008 Jun; 14(11):3520-8. PubMed ID: 18519785
[TBL] [Abstract][Full Text] [Related]
9. Suppression of natural killer cell cytotoxicity in the peripheral blood of patients receiving interferon therapy.
Spina CA; Fahey JL; Durkos-Smith D; Dorey F; Sarna G
J Biol Response Mod; 1983; 2(5):458-69. PubMed ID: 6644350
[TBL] [Abstract][Full Text] [Related]
10. [Comparison of the effects of interferon of various types on the cytotoxic activity of NK cells].
Dozono H; Terashima Y; Saijo N
Gan No Rinsho; 1986 Oct; 32(12):1557-60. PubMed ID: 3783981
[TBL] [Abstract][Full Text] [Related]
11. Natural killer cell IFN-gamma levels predict long-term survival with imatinib mesylate therapy in gastrointestinal stromal tumor-bearing patients.
Ménard C; Blay JY; Borg C; Michiels S; Ghiringhelli F; Robert C; Nonn C; Chaput N; Taïeb J; Delahaye NF; Flament C; Emile JF; Le Cesne A; Zitvogel L
Cancer Res; 2009 Apr; 69(8):3563-9. PubMed ID: 19351841
[TBL] [Abstract][Full Text] [Related]
12. Platelet-derived transforming growth factor-beta down-regulates NKG2D thereby inhibiting natural killer cell antitumor reactivity.
Kopp HG; Placke T; Salih HR
Cancer Res; 2009 Oct; 69(19):7775-83. PubMed ID: 19738039
[TBL] [Abstract][Full Text] [Related]
13. Perturbations of natural killer cell regulatory functions in respiratory allergic diseases.
Scordamaglia F; Balsamo M; Scordamaglia A; Moretta A; Mingari MC; Canonica GW; Moretta L; Vitale M
J Allergy Clin Immunol; 2008 Feb; 121(2):479-85. PubMed ID: 18061653
[TBL] [Abstract][Full Text] [Related]
14. [NK cells in malignant diseases].
Konjević G; Spuzić I
Srp Arh Celok Lek; 1994; 122(5-6):176-8. PubMed ID: 17977422
[TBL] [Abstract][Full Text] [Related]
15. IFN-gamma production and degranulation are differentially regulated in response to stimulation in murine natural killer cells.
Vahlne G; Becker S; Brodin P; Johansson MH
Scand J Immunol; 2008 Jan; 67(1):1-11. PubMed ID: 18028287
[TBL] [Abstract][Full Text] [Related]
16. Natural cytotoxicity in patients undergoing radiation therapy.
Kadish AS; Ghossein NA
Am J Clin Oncol; 1983 Feb; 6(1):53-9. PubMed ID: 6188358
[TBL] [Abstract][Full Text] [Related]
17. Natural killer cell activation after interferon administration in patients with metastatic renal cell carcinoma: an ultrastructural and immunohistochemical study.
Toliou T; Stravoravdi P; Polyzonis M; Vakalikos J
Eur Urol; 1996; 29(2):252-6. PubMed ID: 8647158
[TBL] [Abstract][Full Text] [Related]
18. Combined IFN-gamma-endostatin gene therapy and radiotherapy attenuates primary breast tumor growth and lung metastases via enhanced CTL and NK cell activation and attenuated tumor angiogenesis in a murine model.
Liu LL; Smith MJ; Sun BS; Wang GJ; Redmond HP; Wang JH
Ann Surg Oncol; 2009 May; 16(5):1403-11. PubMed ID: 19263173
[TBL] [Abstract][Full Text] [Related]
19. Natural cytotoxicity and interferon production in human cancer: deficient natural killer activity and normal interferon production in patients with advanced disease.
Kadish AS; Doyle AT; Steinhauer EH; Ghossein NA
J Immunol; 1981 Nov; 127(5):1817-22. PubMed ID: 6170674
[TBL] [Abstract][Full Text] [Related]
20. [Immunomodulatory effect of serum on NK cells in vitro in healthy individuals].
Konjević G; Spuzić I
Glas Srp Akad Nauka Med; 1994; (44):45-54. PubMed ID: 7590414
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
